ISSN: 2155-6148
+44 1223 790975
Anbarasu Annamalai
NHIMS,
Bangalore, Karnataka
India
Research Article
Can Intravenous Dexmedetomidine Prolong Bupivacaine Intrathecal Spinal Anesthesia?
Author(s): Anbarasu Annamalai, Sanjeev Singh, Arti Singh and Deigheidy Ehab MahrousAnbarasu Annamalai, Sanjeev Singh, Arti Singh and Deigheidy Ehab Mahrous
Background and objectives: Different adjuvants have been used to prolong intrathecal spinal anesthesia, with the possible advantages of delayed onset of post-operative pain, delayed and reduced analgesic requirements. The aim of this study was to evaluate the effect ofintravenous dexmedetomidine on prolongation of intrathecal spinal anesthesia, level of sedation, post-operative analgesic requirement.
Methods: Ninety adult patients classified as American Society of Anaesthesiologists physical status (ASA) I or II scheduled for various elective surgical proceduresbelow umbilicus under intrathecal spinal anesthesia were doubleblind randomized to one of three groups. Each patient received 0.5% hyperbaric bupivacaine 2.5 ml intrathecal spinal anesthesia. Group C (control): Patient receiving intravenous normal saline 10 ml over 10 mins (as placebo) .. View More»
DOI:
10.4172/2155-6148.1000372